Metropolis Healthcare Adjusts Evaluation Score Amid Mixed Technical Indicators and Modest Growth

Jul 23 2025 08:20 AM IST
share
Share Via
Metropolis Healthcare has recently adjusted its evaluation score, reflecting changes in stock performance metrics. Technical indicators show mixed signals, with varying trends on weekly and monthly scales. Despite modest sales growth and stagnant operating profit, the company demonstrates high management efficiency and strong institutional interest.
Metropolis Healthcare, a midcap player in the healthcare services industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in the technical trends observed in the stock's performance metrics. Notably, the technical indicators present a mixed picture, with the MACD showing bullish signals on a weekly basis while indicating a mildly bearish stance on a monthly scale. The Relative Strength Index (RSI) presents a bearish outlook weekly, with no significant signals monthly.

The stock's current price stands at 1984.00, slightly above the previous close of 1935.70. Over the past year, Metropolis Healthcare has experienced a return of -2.60%, contrasting with a profit increase of 13.4%. The company's net sales growth has been modest at an annual rate of 9.22% over the last five years, while operating profit growth has been nearly stagnant at 0.10%.

Despite these challenges, Metropolis Healthcare maintains a high management efficiency with a return on capital employed (ROCE) of 26.87% and a low debt-to-equity ratio. The stock is currently trading at a discount compared to its peers' average historical valuations, with institutional holdings at 45.58%, indicating a strong interest from larger investors.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Kamdhenu Ventures Ltd is Rated Sell
25 minutes ago
share
Share Via
Ircon International Ltd is Rated Strong Sell
25 minutes ago
share
Share Via
BMW Industries Ltd is Rated Sell
25 minutes ago
share
Share Via
Veritas (India) Ltd is Rated Strong Sell
25 minutes ago
share
Share Via
Last Mile Enterprises Ltd is Rated Sell
25 minutes ago
share
Share Via
Aveer Foods Ltd is Rated Sell
25 minutes ago
share
Share Via